AstraZeneca Pharma India Limited has informed the Exchange that that as required under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board at its meeting held on……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
